Entrada Therapeutics, Inc.
Status: Publicly traded
Direct answer
Entrada Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TRDA.
Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product candidate,...
Can you invest in Entrada Therapeutics, Inc.?
Yes. Entrada Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TRDA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Entrada Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.